Division of Cardiology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095, USA.
Department of Health Policy and Management, UCLA Fielding School of Public Health, 650 Charles E Young Drive South, Los Angeles, California 90095, USA.
Nat Rev Cardiol. 2016 Jun;13(6):368-78. doi: 10.1038/nrcardio.2016.25. Epub 2016 Mar 3.
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience numerous symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance, and fluid retention. Although the underlying causes of HF vary according to sex, age, ethnicity, comorbidities, and environment, the majority of cases remain preventable. HF is associated with increased morbidity and mortality, and confers a substantial burden to the health-care system. HF is a leading cause of hospitalization among adults and the elderly. In the USA, the total medical costs for patients with HF are expected to rise from US$20.9 billion in 2012 to $53.1 billion by 2030. Improvements in the medical management of risk factors and HF have stabilized the incidence of this disease in many countries. In this Review, we provide an overview of the latest epidemiological data on HF, and propose future directions for reducing the ever-increasing HF burden.
心力衰竭(HF)是一个迅速增长的公共卫生问题,全球估计有超过 3770 万人患有该病。HF 是一种继发于多种病因的心脏功能障碍的共同慢性阶段,HF 患者会经历许多影响其生活质量的症状,包括呼吸困难、疲劳、运动耐量差和体液潴留。尽管 HF 的根本病因因性别、年龄、种族、合并症和环境而异,但大多数病例仍然是可以预防的。HF 与发病率和死亡率的增加相关,并给医疗保健系统带来了巨大负担。HF 是成年人和老年人住院的主要原因。在美国,HF 患者的总医疗费用预计将从 2012 年的 209 亿美元增加到 2030 年的 531 亿美元。许多国家对危险因素和 HF 的医疗管理的改进稳定了该病的发病率。在这篇综述中,我们概述了 HF 的最新流行病学数据,并提出了减少不断增加的 HF 负担的未来方向。